Kiniksa Pharmaceuticals International, plc (KNSA): Ownership & Insider Activity
Insider (Form 4) activity for KNSA. No matching institutional position was found in our retained 13F coverage.
Reported Holders
0
13F filers
Aggregate Value
$0
Across holders
Last Price
—
EOD close
Sector
—
GICS
No matching institutional position for KNSA was found in the retained filings from managers we track. This does not mean the company has no institutional shareholders.
Recent insider activity
Form 4 purchases and sales · 17 Aug 2026 – 14 Nov 20260 buyers · $05 sellers · $78.2M51 transactions
| Insider ⇅ | Trades ⇅ | Bought ⇅ | Sold ⇅ | Largest ⇅ | Latest ▼ | |
|---|---|---|---|---|---|---|
| Megna Michael R CHIEF ACCOUNTING OFFICER | 8 0 buy · 8 sell | — | $4.5M | $1.1M | 9 Nov 2026SEC ↗ | |
| Patel Sanj K CHAIRMAN & CEO | 19 0 buy · 19 sell | — | $51.7M | $13.6M | 4 Nov 2026SEC ↗ | |
| Moat Ross CHIEF OPERATING OFFICER | 11 0 buy · 11 sell | — | $9.6M | $3.5M | 2 Nov 2026SEC ↗ | |
| Paolini John F. CHIEF MEDICAL OFFICER | 10 0 buy · 10 sell | — | $8.9M | $3.8M | 2 Nov 2026SEC ↗ | |
| Ragosa Mark CHIEF FINANCIAL OFFICER | 3 0 buy · 3 sell | — | $3.4M | $1.3M | 2 Nov 2026SEC ↗ |
Distinct buyers and sellers may overlap. “Largest” is the largest reported transaction value in this window. Expand a row to see up to five recent filings.